share_log
Reuters ·  Apr 26 07:01
Acrivon Therapeutics Inc : BMO Raises Target Price to $25 From $18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment